Therefore, to further prove the influence of LCK expression on the response to immunotherapy, we used the MCP-counter algorithm to generate an immune score heatmap based on the differences in LCK expression in the TCGA data (Figure 10D,E); the results showed that the immune score of the group with high LCK expression was significantly higher than that of the group with low LCK expression, p < 0.05 (the higher the immune score, the higher the sensitivity of tumour patients to drugs). This evidence concerns the gene LCK and neoplasm.